Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: Association with hepatitis B related advanced liver disease and cancer

Gene

Volumn 519, Issue 2, 2013, Pages 231-237

  Bose, Sujoy ^a,b   Tripathi, Dinesh M ^a,d   Sukriti, ^a   Sakhuja, Puja ^a   Kazim, Syed N ^c   Sarin, Shiv K ^a,d  

^a G B PANT HOSPITAL   (India)

^b GAUHATI UNIVERSITY   (India)

^c JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^d INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

Cyp2E1; Hepatitis B virus; HOGG1; Liver disease; XRCC1

Indexed keywords

ADULT; ALLELE; ARTICLE; CLINICAL ASSESSMENT TOOL; CODON; CONTROLLED STUDY; CYP2E1 GENE; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME; GENOTYPE; HEPATITIS B; HETEROZYGOSITY; HISTOLOGY ACTIVITY INDEX; HOGG1 GENE; HOMOZYGOSITY; HUMAN; INFECTION; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WILD TYPE; XRCC1 GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CYTOCHROME P-450 CYP2E1; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR; DNA-BINDING PROTEINS; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES; RISK FACTORS; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84875603308     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.02.025     Document Type: Article

References (61)

1. Caldecott K.W., et al. XRCC1 polypeptide interacts with DNA polymerase β and possibly poly (ADP-Ribose) polymerase, and DNA ligase III is a novel molecular 'nick sensor' in vitro. Nucleic Acids Res. 1996, 24:4387-4394.
2. Camus A.M., et al. High variability of nitrosamine metabolism among individuals: role of cytochrome P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol. Carcinog. 1993, 7:268-275.
3. Chen C.J., et al. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1997, 12:S294-S308.
4. Cho E.Y., et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1100-1104.
5. Dominguez-Malagaon I.I., Gayatan-Graham S. Hepatocellular carcinoma: an update. Ultrastruct. Pathol. 2001, 25:497-516.
6. Duell E.J., et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000, 21:965-971.
7. Han J., et al. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res. 2003, 63:8536-8541.
8. Hayashi S., et al. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 1991, 110:559-565.
9. Hildesheim A., et al. Cytochrome P450 2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case control study conducted in Taiwan. Cancer Epidemiol. Biomarkers Prev. 1995, 4:607-610.
10. Hu J.J., et al. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001, 22:917-922.
11. Hung R.J., et al. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 2005, 162:925-942.
12. Ide H., Kotera M. Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol. Pharm. Bull. 2004, 27:480-485.
13. Ingelman-Sundberg M., et al. Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 1993, 10:447-452.
14. Jiao X., et al. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int. J. Cancer 2007, 121:501-505.
15. Kang J.S., et al. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res. 2007, 67:11141-11146.
16. Kato S., et al. Cytochrome P450II-E1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res. 1992, 52:6712-6715.
17. Kiran M., et al. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol. Cell. Biochem. 2009, 327:7-13.
18. Kirk G.D., et al. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol. Biomarkers Prev. 2005, 14:373-379.
19. Knodell R.G., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1995, 1:431-435.
20. Kohno T., et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16:3219-3225.
21. Koop D.R. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 1992, 6:724-730.
22. Kubota Y., et al. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J. 1996, 15:6662-6670.
23. Ladero J.M., et al. Rsa I polymorphism at the cytochrome p4502E1 locus and risk of hepatocellular carcinoma. Gut 1996, 39:330-333.
24. London S.J., et al. Lung cancer risk in relation to the CYP2E1 rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles Country. Pharmacogenetics 1996, 6:151-158.
25. Lu X.M., et al. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China. World J. Gastroenterol. 2005, 11:3651-3654.
26. Lucas D., et al. Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chloroxazone hydroxylation. Fundam. Clin. Pharmacol. 1998, 12:553-558.
27. Maezawa Y., et al. Association between restriction fragment length polymorphism of the human cytochrome p450IIEI gene and susceptibility to alcoholic liver cirrhosis. Am. J. Gastroenterol. 1994, 89:561-565.
28. Marsin S., et al. Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J. Biol. Chem. 2003, 278:44068-44074.
29. McCarver D.G., et al. A genetic polymorphism in the regulatory sequences of human Cyp2E1: association with increased chloroxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol. Appl. Pharmacol. 1998, 152:276-281.
30. McKillop I.H., et al. Molecular pathogenesis of hepatocellular carcinoma. J. Surg. Res. 2006, 136:125-135.
31. Nelson H.H., et al. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res. 2002, 62:152-155.
32. Nomura F., et al. Transcriptional activity of the tandem repeat polymorphism in the 5' flanking region of the human Cyp2E1gene. Alcohol. Clin. Exp. Res. 2003, 27:425-426.
33. Pan H.Z., et al. Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. Asian Pac. J. Cancer Prev. 2011, 12(11):2947-2950.
34. Park J.Y., et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol. Biomarkers Prev. 2002, 11:23-27.
35. Park H.W., et al. The hOGG1 Ser326Cys polymorphism is not associated with colorectal cancer. Risk J. Epidemiol. 2007, 17:156-160.
36. Ramachandran S., et al. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 2006, 42:350-362.
37. Ramaiah S.K., et al. Cytochrome P450 2E1 induction increases thioacetamide liver injury in diet restricted rats. Drug Metabolic Disopos. 2001, 29:1088-1095.
38. Ronen A., Glickman B.W. Human DNA repair genes. Environ. Mol. Mutagen. 2001, 37:241-283.
39. Sakamoto T., et al. Ser326Cys polymorphism and risk of hepatocellular carcinoma among Japanese. J. Epidemiol. 2006, 16:233-239.
40. Sambrook J., Fritsh E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, 9.16-9.19. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
41. Sarin S.K., et al. Hepatocellular carcinoma in India: an analysis of possible etiological factors. Ind. J. Gastroenterol. 1998, 17(1). abs F6.
42. Seeberg E., et al. The base excision repair pathway. Trends Biochem. Sci. 1995, 20:397-401.
43. Shen M., et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1234-1240.
44. Sheng Y., et al. Study on the relationship between familial clustering of hepatocellular carcinoma and polymorphism of cytochrome P450 2E1 gene in Zhuang population, Guangxi. Zhonghua Liu Xing Bing Xue Za Zhi 2009, 30:151-155.
45. Shu X.O., et al. A population based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1462-1467.
46. Song B.J., et al. Ethanol-induced cytochrome p450 (CYP2E1): biochemistry, molecular biology and clinical relevance: 1996 update. Alcohol. Clin. Exp. Res. 1996, 20:138A-146A.
47. Srivastava A., et al. Single-nucleotide polymorphisms of DNA repair genesOGG1 and XRCC1: association with gallbladder cancer in North Indian population. Ann. Surg. Oncol. 2009, 16:1695-1703.
48. Stern M.C., et al. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 2001, 10:125-131.
49. Sturgis E.M., et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999, 20:2125-2129.
50. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus; evidence for a causal association. Prog. Med. Virol. 1978, 24:40.
51. Tabor E. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor genes. Princes Takamatsu Symp. 1995, 25:151-161.
52. Tan W., et al. Impact of genetic polymorphism in cytochrome P450 2E1 and glutathione S-transferases M1, T1 and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol. Biomarkers Prev. 2000, 9:551-556.
53. Tsutsumi M., et al. Genetic polymorphisms of cytochrome p4502E1 related to the development of alcoholic liver disease. Gastroenterology 1994, 107:1430-1435.
54. Watanabe J., et al. Pst I and rsa I RFLPs in complete linkage disequilibrium at the Cyp2E1 gene. Nucleic Acid Res. 1990, 8:7194.
55. Watanabe J., et al. Different regulation and expression of the human Cyp2E1gene due to RsaI polymorphism in the 5' flanking region. J. Biochem. (Tokyo) 1994, 116:321-326.
56. Wu X., et al. Associations between cytochrome P450IIE1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 1997, 18:967-973.
57. Yu M.W., et al. Cytochrome p4502E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995, 109:1266-1273.
58. Yu M.W., et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J. Natl. Cancer Inst. 2003, 95:1485-1488.
59. Yuan T., et al. Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk. Dig. Dis. Sci. 2012, 57(9):2451-2457.
60. Zhang H., et al. Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells. Carcinogenesis 2007, 28:1629-1637.
61. Zhou W., et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2003, 12:359-365.